Bio-Rad Laboratories | BIO - Assets


Bio-Rad Laboratories reported $10.25B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Agilent USD 13.07B 252M Mar/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Bio Techne USD 2.55B 27.9M Mar/2026
Bio-Rad Laboratories USD 10.25B 462M Jun/2026
Bruker USD 6.05B 77.8M Jun/2026
Charles River Laboratories USD 7.53B 198.16M Jun/2026
Danaher USD 92.37B 8.82B Jun/2026
General Electric Aerospace USD 127.67B 773M Jun/2026
Illumina USD 6.65B 91M Jun/2026
IQVIA Holdings USD 29.88B 206M Jun/2026
Laboratory Of America USD 18.53B 554.8M Jun/2026
Merck USD 128.68B 8.18B Mar/2026
Mettler Toledo International USD 3.67B 2.03M Jun/2026
Myriad Genetics USD 638.9M 34.8M Jun/2026
OraSure Technologies USD 379.17M 24M Mar/2026
Pacific Biosciences Of California USD 782.36M 1.72M Mar/2026
Quest Diagnostics USD 16.94B 266M Jun/2026
Repligen USD 2.95B 19.41M Jun/2026
Revvity USD 12.05B 49.24M Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Siemens EUR 167.97B 2.16B Mar/2026
Standard Biotools USD 639.11M 71.36M Mar/2026
Thermo Fisher Scientific USD 113.17B 107M Jun/2026
Tosoh JPY 1.47T 59.99B Jun/2026
Waters USD 24.75B 220M Jun/2026